Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026)

Lucid Diagnostics (LUCD) posted Total Non-Current Liabilities of $30.1 million for Q1 2026, up 446.02% on a QoQ basis from $5.5 million in Q4 2025, and up 459.94% year-over-year from $5.4 million in Q1 2025.

Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Lucid Diagnostics' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $30.1 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 459.94% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 459.94% YoY) and the FY2025 annual result came in at $5.5 million, down 18.07% from the prior year.
  • Total Non-Current Liabilities was $30.1 million for Q1 2026 at Lucid Diagnostics, up from $5.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $30.1 million in Q1 2026 and bottomed at $1.3 million in Q2 2022.
  • A 5-year average of $9.4 million and a median of $6.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 1132.84% — and 2024, when it tumbled 62.59%.
  • Lucid Diagnostics' Total Non-Current Liabilities stood at $1.3 million in 2022, then soared by 1119.27% to $15.6 million in 2023, then plunged by 56.98% to $6.7 million in 2024, then declined by 18.07% to $5.5 million in 2025, then soared by 446.02% to $30.1 million in 2026.
  • Business Quant data shows LUCD's Total Non-Current Liabilities at $30.1 million in Q1 2026, $5.5 million in Q4 2025, and $5.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Lucid Diagnostics 133.09 Mn 105.22 Mn -325,000.00 30.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.08 Mn
Dec 31, 2025 5.51 Mn
Sep 30, 2025 5.06 Mn
Jun 30, 2025 5.51 Mn
Mar 31, 2025 5.37 Mn
Dec 31, 2024 6.72 Mn
Sep 30, 2024 6.06 Mn
Jun 30, 2024 6.93 Mn
Mar 31, 2024 7.01 Mn
Dec 31, 2023 15.63 Mn
Sep 30, 2023 16.20 Mn
Jun 30, 2023 15.81 Mn
Mar 31, 2023 12.32 Mn
Jun 30, 2022 1.28 Mn
Mar 31, 2022 1.46 Mn